InSnip Pure Signal, No Noise
✓ Source-backedMoney & Work
Amplia and Eli Lilly back combined lung cancer trial
The companies will test a combination of their therapies in non small cell lung cancer.
Why it mattersA trial with Lilly can lift Amplia's profile and signal whether its cancer program has wider potential.
Free. Be genuinely informed in 5 minutes a day. No signup, no noise.
Get the free app, read the whole feed
InSnip turns the day's news into short, source-backed snippets with a plain why it matters line. The signal, not the scroll.